Schering-Plough
SGP
#508
Rank
NZ$81.12 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: NZ$3.59 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of NZ$3.59 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008NZ$3.59 B
2006NZ$2.60 B198.39%
2005NZ$0.87 B-395.83%
2004-NZ$0.3 Billion265.22%
2003-NZ$80.79 Million-102.01%
2002NZ$4.02 B3.62%
2001NZ$3.88 B-5.39%
2000NZ$4.10 B
1998NZ$3.38 B22.34%
1997NZ$2.76 B38.9%
1996NZ$1.99 B